Connect with us


HempAmericana Inc (OTCMKTS:HMPQ): Do the Math



HempAmericana Inc (OTCMKTS:HMPQ) would appear to be mispriced according to a basic interpretation of the company’s recent communications and the overall industry and market context in which it exists. This conclusion is driven by the sense that the CBD, hemp, and cannabis space has probably bottomed, and that HMPQ is probably verging on appreciable and tangible sales growth in a manner and to a degree that the market will no longer be able to ignore.

Let’s first turn to the former of these allegations: the CBD, hemp, and cannabis space has probably bottomed.


The Big Green Turn

It’s important to understand that, by this idea of a “bottom” in the green machine, we mean a cyclical inflection from the longstanding 18-month bear market to a new bull cycle that sees the stocks in the space, including HempAmericana, witness powerful price-per-share appreciation.

The driver is partly seasonal, partly situational, and partly cyclical.

The seasonal influence is rooted in the fact that some significant portion of the cannabis cash crop is brought to market from outdoor growers (as opposed to greenhouse and indoor growers), who are now just starting to tend to the crops that will become the fall harvest. In other words, the supply of cannabis coming to market has started to become seasonally reduced during the period from April to October, meaning that we are now in the early stages of that seasonal dip in supply.

Situationally, demand for cannabis is clearly on the upswing during the stay-at-home coronavirus response. This is due to some presumed combination of anxiety and boredom.

Finally, the CBD, hemp, and cannabis space had already been through an extreme ringer by the time we hit the broad coronavirus bear market. In other words, we had already whittled down the stocks in this space to bare bones when the broad market wind started to blow. That likely over-exaggerated the dynamic, driving these stocks to an undervalued threshold – an overextension of the downward trend.


The Stars Align

At the same time that we are starting to see the right type of signals to suggest that money will likely be flowing back into CBD and hemp plays in coming months, we are also seeing the right type of signals from HMPQ: the ecommerce engine is up and running live with a payment processor capable of taking payments from all popular methods of commerce, the company is partnering with Alibaba’s winning B2B platform as a supplier, HempAmericana just gobbled up a vast affiliate marketing network of over 400 relevant domains and sites to point back to its store, and just made important announcements about beefing up its marketing and customer service capabilities.

All of this comes on the heels of news that it had built up a strong inventory of high-quality CBD products and after constructing a truly state-of-the-art extraction and production facility in Maine with a supply chain already in place.

Those are really all of the pieces to churning out really nice financials over coming quarters and it puts the company in a place it has never been before – prepotency across the board.

To help add some extra juice and get the ball rolling on the top line, the company also just announced that it is now marketing its products on the Groupon platform.

“As part of our aggressive pursuit of brand and product sales growth, we are launching a promotional campaign designed to create further market penetration through the largest digital coupon platform on the planet,” commented Salvador Rosillo, CEO of HempAmericana. “Millions of people search for deals on Groupon, providing us with a resource for generating immediate sales growth and relationships with new customers that hold the potential for repeat business for years to come.”


This article is part of Networks. Read the Networks Disclaimer.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.



Ventura Cannabis and Wellness Corp (OTCMKTS:CVHIF) Disposes Of Addiction Services Business: Posts Cannabis Revenues Of $1.7 Million In Q1 2021

Post Views: 136 Ventura Cannabis and Wellness Corp (OTCMKTS:CVHIF) reported revenues of $1.7 million from the cannabis business in Q1...

Business2 days ago

Cronos Group Inc (NASDAQ:CRON) Commences Sale Of Dried Cannabis Products Under Peace Naturals Brand In Israel: Posts $9.9 Million In Revenues In Q2 2020

Post Views: 136 Cronos Group Inc (NASDAQ:CRON) reported revenues of $9.9 million in Q2 2020. It posted a growth of...

Business5 days ago

Plus Products Inc (OTCMKTS:PLPRF) Introduces High Cubes Brand In The Californian Market For Recreational Use

Post Views: 62 Plus Products Inc (OTCMKTS:PLPRF) unveiled high THC concentrated Gummies under High Cubes Brand for recreational use in...

Business6 days ago

Emerald Health Therapeutics Inc. (OTCMKTS:EMHTF) Introduces Pure Sunfarm Products In Manitoba As Its Terminates Facility Agreements

Post Views: 165 Emerald Health Therapeutics Inc. (OTCMKTS:EMHTF) has announced that its cannabis production joint venture Pure Sunfarms has started...

Business1 week ago

Planet 13 Holdings Inc. (OTCMKTS:PLNHF) Signs Purchase Agreement To Acquire 45,000 Sq. ft. Facility In Nevada

Post Views: 256 Planet 13 Holdings Inc. (OTCMKTS:PLNHF) announced the signing of an asset purchase agreement subject to which it...

Business1 week ago

AXIM® Biotechnologies Inc. (OTCMKTS:AXIM) Unveils its NeuCovix™ Test That Can Accurately Classify COVID-19 Neutralization Tests

Post Views: 121 AXIM® Biotechnologies Inc. (OTCMKTS:AXIM) has completed a study focusing on the performance of its NeuCovix™ rapid test...